AMAG Pharmaceuticals Appoints Ricardo Zayas as SVP of Operations

AMAG Pharmaceuticals Inc. (AMAG: News ) appointed Ricardo Zayas as senior vice president of operations. In his new position with AMAG, Zayas will be responsible for leading the company's manufacturing, materials management, quality assurance, quality control, and supply chain functions.

Zayas has over two decades of pharmaceutical operations and commercial manufacturing experience to the Company. Prior to joining AMAG, Zayas was Vice President and General Manager of Operations at Wyeth Pharmaceuticals in Puerto Rico since 2007.

Small Cap Network Issues Analysis of Pharmaceutical Stocks AMAG, ACUR, ACAD

The Small Cap Network, a leading online investment community focused on small cap stocks, has issued an analysis of pharmaceutical stocks AMAG Pharmaceuticals, Inc. (AMAG), Acura Pharmaceuticals Inc. (ACUR), and ACADIA Pharmaceuticals, Inc. (ACAD).

The article explores not just the fundamental aspects of these drug-maker stocks, but also the technical aspects of their charts. For instance, one is an attractive company, but may be overbought for the time being. Another stock is priced under $2.00, and may be attractive based solely on a very inexpensive entry level.